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Abstract Carbohydrates with reactive aldehyde and ketone
groups can undergo Maillard reactions with proteins to form
advanced glycation end products. Oxalate monoalkylamide was
identified as one of the advanced glycation end products formed
from the Maillard reaction of ascorbate with proteins. In these
experiments, we have analyzed human lens proteins immuno-
chemically for the presence of oxalate monoalkylamide. Oxalate
monoalkylamide was absent in most of the very young lenses but
was present in old and cataractous lenses. The highest levels were
found in senile brunescent lenses. Incubation experiments using
bovine lens proteins revealed that oxalate monoalkylamide could
form from the ascorbate degradation products, 2,3-diketogulo-
nate and L-threose. These data provide the first evidence for
oxalate monoalkylamide in vivo and suggest that ascorbate
degradation and its binding to proteins are enhanced during lens
aging and cataract formation.
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1. Introduction
The human lens undergoes numerous physico-chemical
changes during aging. The Maillard reaction, non-enzymatic
condensation of sugars with proteins, has been considered as
one of the mechanisms in lens aging. The end products of this
reaction, referred to as advanced glycation products (AGEs),
have been shown to accumulate with age in lens proteins [1].
In both senile and diabetic cataractous lenses, increased levels
of AGEs have been observed [2,3]. A recent study has shown
that cataracts can be prevented in mildly diabetic animals by
inhibiting the Maillard reaction.
In the human lens, ascorbate (ASC) is present in relatively
large amounts (up to 2 mM) [4] and has been shown to under-
go oxidative degradation with age and cataract formation [5^
9]. In vitro incubation experiments have revealed that the
degradation products of ASC can rapidly react with lens pro-
teins through Maillard reactions to form cross-linked proteins
with characteristic browning and £uorescence. These changes
resemble those occurring in the lens during normal aging and
cataract formation. Several Maillard reaction products, pen-
tosidine, carboxymethyllysine (CML) and LM-1 have been
identi¢ed in the human lens and have been shown to form
from ASC.
Previously, it was shown that oxalate monoalkylamide
(OMA) is a major product in the Maillard reaction initiated
by ASC [10]. Polyclonal antibodies were raised against this
modi¢cation and it was determined that proteins undergoing
Maillard reactions with ASC produce OMA. It was also
shown that Maillard reaction products of sugars such as glu-
cose are not recognized by the antibody, but more recent
experiments reveal that they do produce OMA in long-term
incubations, although at a much smaller amount when com-
pared to ASC. Thus, ASC appears to be the major precursor
of OMA [11]. In this report, we describe the occurrence of
OMA in the human lens and its relation to lens aging and
cataract formation.
2. Materials and methods
Human lenses were obtained from The Cleveland Eye Bank, Cleve-
land, The National Disease Research Interchange, Philadelphia and
The University Hospitals of Cleveland. Bovine lenses were from Pel-
Freeze Biologicals, Rogers (AR, USA). ASC and L-threose were ob-
tained from Sigma Chemical (St. Louis, MO, USA). 2,3-Diketogulo-
nate (DKG) was synthesized by the method of Otsuka et al [12]. The
anti-OMA antibody was produced in rabbits [11] and the IgG fraction
from the antiserum was puri¢ed on a protein-G column. BSA-OMA
was prepared by the previously published method [11].
2.1. Human lens proteins
Each human lens was decapsulated and extracted by homogeniza-
tion in 2 ml PBS, followed by centrifugation at 16 000Ug for 30 min.
The supernatant was dialyzed against 2 l PBS for 24 h, lyophilized
and stored at 380‡C until use. 61 Wg protein was used from each
sample for the competitive enzyme-linked immunosorbent assay (ELI-
SA).
2.2. Incubation of bovine lens water-soluble proteins (BLP) with ASC
and ASC oxidation products
Bovine lenses were extracted as described elsewhere [13]. 10 mg/ml
water-soluble protein in 0.2 M sodium phosphate bu¡er (pH 7.4) was
incubated with 100 mM of one of ASC, DKG or L-threose, for
2 weeks at 37‡C and dialyzed against PBS for 48 h and lyophilized.
2.3. ELISA
The microplate wells were coated with 1 mg/well BSA-OMA in 0.02
M sodium carbonate bu¡er, pH 9.7, overnight at 4‡C. The wells were
washed 2U with PBS containing 0.1% Tween-20 (PBST) and blocked
with 3% gelatin in PBST for 2 h at room temperature in a humid
chamber. Following washing 3U with PBST, antibody (1:1000 dilu-
tion in PBST, IgG fraction from the antiserum puri¢ed on protein-G
Sepharose) was added directly or pre-incubated (1 h at 37‡C) with the
test protein and incubated for 2 h. In the case of BLP incubation
experiments, antiserum was directly used at a 1:10 000 dilution. The
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wells were then incubated with alkaline phosphatase-conjugated goat
anti-rabbit IgG for 2 h (1:60 000 dilution in PBST), washed four times
with PBST and incubated with p-nitrophenylphosphate substrate at
pH 9.8 until the OD at 406 nm reached about 0.6.
2.4. Western blotting
The water-soluble lens proteins (20 Wg) from a young (16 years) and
an old lens (65 years) were subjected to electrophoresis on a 10% SDS
gel (60 min, 40 mA). The proteins were electrophoretically transferred
to a nitrocellulose membrane (Bio-Rad laboratories, Richmond, CA,
USA) for 2 h at 90 V. The membrane was blocked with 5% non-fat
dry milk in Tris-bu¡ered saline-Tween-20 (TBST) bu¡er, pH 7.0
(blotto), overnight at 4‡C and then allowed to react for 2 h with
the anti-OMA antibody (1:250 diluted in blotto). In an experiment
to check the speci¢city of the reaction of anti-OMA antibody with
lens proteins, the antibody was pre-incubated with 50 mg BSA-OMA
at 37‡C for 2 h and then at 4‡C for 16 h prior to incubation with the
membrane. The membrane was washed three times with TBST bu¡er
and incubated with 1:3000 diluted anti-rabbit IgG coupled to horse-
radish peroxidase (Sigma) in blotto for 1 h, washed at least 8^10 times
with TBST bu¡er and developed with the Supersignal chemilumines-
cence substrate kit (Pierce, Rockford, IL, USA) for 3^5 min and
exposed to X-ray ¢lm (re£ection/autoradiography ¢lm from NEN
Life Science Products, Boston, MA, USA) in a dark room.
2.5. Statistical analysis
Di¡erences between groups were analyzed by ANOVA using the
Fisher PLSD test. P6 0.05 was considered signi¢cant.
3. Results
The IgG fraction was puri¢ed from OMA antiserum on a
protein-G Sepharose column and used in a competitive ELI-
SA to determine the presence of OMA in human lens pro-
teins. Three representative lenses, young (30 years), catarac-
tous (68 years) and brunescent (70 years), were used to test the
e¡ect of an increasing protein concentration on the immuno-
reactivity. A maximum of 5, 14 and 26% inhibition was ob-
served for young, cataractous and brunescent lens proteins,
respectively (Fig. 1). The percent inhibition corresponds to
almost three and ¢ve times more antigen in the cataractous
and the brunescent lens relative to the young lens.
The immunoreactivity in individual young (11^33 years),
old (58^75 years), cataractous (59^85 years), diabetic (17^67
years, type II, non-cataractous) and brunescent lenses (60^80
years) was investigated. Most of the young lenses failed to
show immunoreactivity (Fig. 2). Almost an equal immuno-
reactivity was observed for old and diabetic lenses. On the
other hand, the mean level in cataractous lenses was about
1.5 times higher than the mean level in old lenses. Brunescent
lenses showed signi¢cantly higher levels (percent inhibition:
30.35 þ 14.28; old 9.49 þ 7.99) when compared to the rest of
the lenses (P6 0.05).
Western blotting was performed to further con¢rm the im-
munoreactivity in human lenses. The immunoreactivity was
primarily localized to one of the protein bands in the high
molecular weight region (Fig. 3) and the molecular weight
of this band appears to be about 45 kDa. Di¡used immuno-
Fig. 1. The e¡ect of an increasing lens protein concentration on the
immunoreactivity against OMA antibody. Representative samples
from young (30 years old), cataractous (68 years) and brunescent
(70 years) lenses were used. Immunoreactivity was determined by a
competitive ELISA.
Fig. 2. The e¡ect of age, diabetes and cataract on the immunoreac-
tivity of human lens proteins against OMA antibody. 61 Wg protein
from each lens was tested in a competitive ELISA as described in
Section 2.
Fig. 3. Western blotting of human lens water-soluble proteins using
OMA antibody. 10 Wg protein from a young (16 years) and an old
lens (65 years) was subjected to electrophoresis on a 10% SDS gel.
The proteins were electrophoretically transferred to a nitrocellulose
membrane and reacted with OMA antibody followed by goat anti-
rabbit IgG coupled to horseradish peroxidase. The immunoreactivity
was detected using the Pierce Supersignal substrate kit. Lanes 1 and
2 are from Coomassie blue-stained SDS-PAGE of 16 year and
65 year old lens proteins, lanes 3 and 4 are from corresponding
Western blotting.
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reactivity could be seen in other higher molecular weight pro-
teins. The protein band of 45 kDa could be a dimer of crys-
tallins, whereas the di¡used streaks at the high molecular
region are probably from highly cross-linked proteins that
occur during aging and also during the Maillard reaction
[14]. Thus, it can be concluded that formation of OMA in
vivo occurs concurrently with protein cross-linking. The im-
munoreactivity could be completely abolished by pre-incuba-
tion of the antibody with BSA-OMA. Furthermore, normal
rabbit IgG at the same concentration as OMA-IgG failed to
show immunoreactivity (data not shown). These results sug-
gest that the antibody speci¢cally reacted with OMA, present
in lens proteins.
To determine the formation of OMA from ASC and its
degradation products, incubation experiments were per-
formed. Water-soluble BLPs were incubated at physiological
conditions with ASC and its degradation products, DKG and
L-threose, and tested for immunoreactivity using antiserum
against OMA. OMA synthesis occurred during all three incu-
bations. A slightly higher immunoreactivity is detectable in
the samples that were incubated with DKG compared to
those with L-threose or ASC (Fig. 4). The relative inhibition
was 66.1, 81.3 and 71.1 for 10 mg protein incubated with
ASC, DKG and L-threose, respectively.
The Western blotting results (Fig. 5) showed a di¡used
immunoreactivity in high molecular weight proteins. The im-
munoreactivity of the native protein was negligible as opposed
to the extensive immunoreactivity in the high molecular
weight region in ASC-modi¢ed proteins. This suggests that
incubation of proteins with ASC and its oxidation products
leads to extensive cross-linking and formation of high molec-
ular weight protein aggregates that do not migrate well in the
gel but contain signi¢cant amounts of OMA. The protein
band of 45 kDa present in the human lens was not apparent
in ASC-modi¢ed bovine proteins possibly because of its fur-
ther modi¢cation and/or cross-linking with other proteins in
the high molecular weight region. Although OMA does not
cross-link proteins, its presence in high molecular weight pro-
teins suggests that its formation occurs concurrently to cross-
linking AGEs. Taken together, these results suggest that
DKG and other degradation products of ASC are likely to
be the major source of OMA in the lens.
A possible pathway of OMA synthesis is shown in Fig. 6. A
possible mechanism is that DKG ¢rst gives rise to a Schi¡’s
base which then degrades to produce OMA and threonic acid.
This is based on the reported formation of oxalate from DKG
[15]. The reaction pathway of OMA formation from threose is
unclear, but it is obvious that several oxidation steps are in-
volved. Oxidation reactions of the Amadori product of
L-threose and other K-amino-ketones are very likely, because
it has been shown that structures of this type are spontane-
ously oxidized by oxygen [16,17]. Retro-aldol cleavage and
further oxidation would then lead to the formation of OMA.
Fig. 4. Formation of OMA in water-soluble BLPs incubated with
ASC and its degradation products. Lens proteins (10 mg/ml) in
0.2 M phosphate bu¡er were incubated with 100 mM indicated car-
bohydrate, dialyzed and used in a competitive ELISA.
Fig. 5. Western blotting of BLPs modi¢ed by ASC and its degrada-
tion products. A: Coomassie blue-stained SDS-PAGE gel and B:
Western blotting using antiserum against OMA. Lanes 1, BLP incu-
bated without carbohydrate; lanes 2, BLP+ASC; lanes 3,
BLP+DKG and lanes 4, BLP+threose. Other details are the same
as in Fig. 3.
Fig. 6. Possible pathway of OMA formation from ASC. ASC must
undergo oxidation to form OMA in proteins.
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4. Discussion
Several previous independent studies have suggested that
human lens proteins may undergo Maillard reactions by
ASC oxidation products during aging and cataractogenesis.
Although no direct evidence is available, results from in vitro
incubation experiments,and detection of Maillard products
that could be synthesized from ASC oxidation products pro-
vided support for this assumption. The present study estab-
lishes, for the ¢rst time, that ASC-mediated Maillard reac-
tions occur in the human lens and may play a role in
protein modi¢cations during aging and cataract formation.
For the synthesis of OMA, ASC must be oxidized before
the oxidation products react with protein lysine residues. ASC
is present in relatively large amounts in the human lens, pos-
sibly to protect lens proteins from oxidative damage. In the
lens, glutathione (GSH) and enzymes maintain ASC in its
reduced state [18^20]. However, during aging and cataract
formation, the lens GSH level is severely depleted which could
lead to an enhanced oxidation of ASC. The detection of in-
creasing amounts of DHA and 2,3-DKG in relation to the
severity of cataract [5] supports this view. Additionally, cal-
cium oxalate, which may originate from ASC oxidation [21]
was found in cataractous lenses. It was reported that there is a
considerable decrease in the amount of ASC in brunescent
lenses, suggesting its accelerated oxidation [18]. The ¢nding
in the present study that brunescent lenses contain the highest
immunoreactivity for the OMA antibody supports an en-
hanced ASC oxidation in these lenses.
Diabetic lenses were expected to have a higher OMA im-
munoreactivity than age-matched normal lenses, because dia-
betes, at least in animals, results in a drastic depletion of GSH
in the lens. This could lead to oxidation of ASC and forma-
tion of OMA. The following observations support this view.
Experimental diabetes in rats causes a decrease in reduced
ASC [22] and in organ-cultured galactosemic rat lenses, an
increase of the ASC-mediated glycation has been observed
[23], suggesting an enhanced ASC oxidation and Maillard
reactions during hyperglycemia. However, we found almost
identical levels of OMA immunoreactivity in diabetic and
non-diabetic lenses. The diabetic lenses that we used were
non-cataractous and therefore, the extent of ASC oxidation
may not have been signi¢cantly di¡erent when compared to
age-matched old lenses. Experimental diabetic cataract may
be useful in understanding ASC oxidation, OMA formation
and their relation to lens GSH.
In summary, this study provides evidence for OMA in the
human lens. OMA is most likely derived from ASC-mediated
Maillard reactions. The relevance of OMA to lens aging and
development of cataract remains to be studied.
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